Literature DB >> 5109101

Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.

K Samuelsson, R Zetterström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5109101     DOI： 10.3109/00365517109080235

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  14 in total

1.  A specific ultrastructural marker for disseminated lipogranulomatosis (Faber).

Authors:  C Schmoeckel; M Hohlfed
Journal:  Arch Dermatol Res       Date:  1979-10       Impact factor: 3.017

2.  Sphingolipids and their precursors in human brain (normal and MS).

Authors:  B Gerstl; M G Tavaststjerna; L F Eng; J K Smith
Journal:  Z Neurol       Date:  1972

3.  Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.

Authors:  M Sugita; P Connolly; J T Dulaney; H W Moser
Journal:  Lipids       Date:  1973-07       Impact factor: 1.880

4.  Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.

Authors:  Fabian P S Yu; Diana Islam; Jakub Sikora; Shaalee Dworski; Jiří Gurka; Lucía López-Vásquez; Mingyao Liu; Wolfgang M Kuebler; Thierry Levade; Haibo Zhang; Jeffrey A Medin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-22       Impact factor: 5.464

5.  Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1.

Authors:  Jie Zhou; Marcel Tawk; Francesco Danilo Tiziano; Julien Veillet; Monica Bayes; Flora Nolent; Virginie Garcia; Serenella Servidei; Enrico Bertini; Francesc Castro-Giner; Yavuz Renda; Stéphane Carpentier; Nathalie Andrieu-Abadie; Ivo Gut; Thierry Levade; Haluk Topaloglu; Judith Melki
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

6.  Farber disease with prolonged survival.

Authors:  A Fiumara; F Nigro; L Pavone; H W Moser
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Farber's disease in two siblings, sural nerve and subcutaneous biopsies by light and electron microscopy.

Authors:  J F Pellissier; M Berard-Badier; N Pinsard
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

8.  Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.

Authors:  T Momoi; Y Ben-Yoseph; H L Nadler
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

9.  A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.

Authors:  U Burck; H W Moser; H H Goebel; R Grüttner; K R Held
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

10.  On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging.

Authors:  E Ellen Jones; Shaalee Dworski; Daniel Canals; Josefina Casas; Gemma Fabrias; Drew Schoenling; Thierry Levade; Chadrick Denlinger; Yusuf A Hannun; Jeffrey A Medin; Richard R Drake
Journal:  Anal Chem       Date:  2014-08-08       Impact factor: 6.986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.